These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29557740)

  • 1. PI3K Signaling in Chronic Obstructive Pulmonary Disease: Mechanisms, Targets, and Therapy.
    Pirozzi F; Ren K; Murabito A; Ghigo A
    Curr Med Chem; 2019; 26(16):2791-2800. PubMed ID: 29557740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration.
    Horiguchi M; Oiso Y; Sakai H; Motomura T; Yamashita C
    J Control Release; 2015 Sep; 213():112-119. PubMed ID: 26160307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K signalling in chronic obstructive pulmonary disease and opportunities for therapy.
    Moradi S; Jarrahi E; Ahmadi A; Salimian J; Karimi M; Zarei A; Azimzadeh Jamalkandi S; Ghanei M
    J Pathol; 2021 Aug; 254(5):505-518. PubMed ID: 33959951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.
    Hsu AC; Starkey MR; Hanish I; Parsons K; Haw TJ; Howland LJ; Barr I; Mahony JB; Foster PS; Knight DA; Wark PA; Hansbro PM
    Am J Respir Crit Care Med; 2015 May; 191(9):1012-23. PubMed ID: 25751541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
    Barnes PJ
    Semin Respir Crit Care Med; 2015 Aug; 36(4):508-22. PubMed ID: 26238638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging pharmaceutical therapies for COPD.
    Lakshmi SP; Reddy AT; Reddy RC
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2141-2156. PubMed ID: 28790817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD.
    Banerjee A; Koziol-White C; Panettieri R
    Curr Opin Pharmacol; 2012 Jun; 12(3):287-92. PubMed ID: 22365729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
    Beck JT; Ismail A; Tolomeo C
    Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease.
    To Y; Ito K; Kizawa Y; Failla M; Ito M; Kusama T; Elliott WM; Hogg JC; Adcock IM; Barnes PJ
    Am J Respir Crit Care Med; 2010 Oct; 182(7):897-904. PubMed ID: 20224070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for chronic obstructive pulmonary disease in the 21st century.
    Donnelly LE; Rogers DF
    Drugs; 2003; 63(19):1973-98. PubMed ID: 12962514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).
    Sala V; Margaria JP; Murabito A; Morello F; Ghigo A; Hirsch E
    Curr Heart Fail Rep; 2017 Jun; 14(3):187-196. PubMed ID: 28451983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new drugs for COPD.
    Barnes PJ
    Curr Med Chem; 2013; 20(12):1531-40. PubMed ID: 22963554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological targets for therapeutic interventions in COPD: clinical potential.
    Pelaia G; Vatrella A; Gallelli L; Renda T; Caputi M; Maselli R; Marsico SA
    Int J Chron Obstruct Pulmon Dis; 2006; 1(3):321-34. PubMed ID: 18046869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.
    Barnes PJ
    Pharmacol Rev; 2016 Jul; 68(3):788-815. PubMed ID: 27363440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives.
    Vyas P; Vohora D
    Curr Drug Targets; 2017; 18(14):1622-1640. PubMed ID: 27739372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of phosphoinositol 3 kinase and NFκB for the treatment of chronic obstructive pulmonary disease.
    Larocca NE; Moreno D; Garmendia JV; De Sanctis JB
    Recent Pat Inflamm Allergy Drug Discov; 2011 Sep; 5(3):178-83. PubMed ID: 21827398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.
    Gupta V; Khan A; Higham A; Lemon J; Sriskantharajah S; Amour A; Hessel EM; Southworth T; Singh D
    Int Immunopharmacol; 2016 Jun; 35():155-162. PubMed ID: 27049289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
    Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
    Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease.
    Marwick JA; Caramori G; Casolari P; Mazzoni F; Kirkham PA; Adcock IM; Chung KF; Papi A
    J Allergy Clin Immunol; 2010 May; 125(5):1146-53. PubMed ID: 20381852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models.
    Baker KE; Bonvini SJ; Donovan C; Foong RE; Han B; Jha A; Shaifta Y; Smit M; Johnson JR; Moir LM
    Pulm Pharmacol Ther; 2014 Dec; 29(2):181-98. PubMed ID: 24929072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.